Literature DB >> 21113240

Controlling subcellular delivery to optimize therapeutic effect.

Mohanad Mossalam1, Andrew S Dixon, Carol S Lim.   

Abstract

This article focuses on drug targeting to specific cellular organelles for therapeutic purposes. Drugs can be delivered to all major organelles of the cell (cytosol, endosome/lysosome, nucleus, nucleolus, mitochondria, endoplasmic reticulum, Golgi apparatus, peroxisomes and proteasomes) where they exert specific effects in those particular subcellular compartments. Delivery can be achieved by chemical (e.g., polymeric) or biological (e.g., signal sequences) means. Unidirectional targeting to individual organelles has proven to be immensely successful for drug therapy. Newer technologies that accommodate multiple signals (e.g., protein switch and virus-like delivery systems) mimic nature and allow for a more sophisticated approach to drug delivery. Harnessing different methods of targeting multiple organelles in a cell will lead to better drug delivery and improvements in disease therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21113240      PMCID: PMC2989634          DOI: 10.4155/tde.10.8

Source DB:  PubMed          Journal:  Ther Deliv        ISSN: 2041-5990


  390 in total

Review 1.  The importomer--a peroxisomal membrane complex involved in protein translocation into the peroxisome matrix.

Authors:  Naganand Rayapuram; Suresh Subramani
Journal:  Biochim Biophys Acta       Date:  2006-08-30

2.  Peroxisome biogenesis in the yeast Hansenula polymorpha: a structural and functional analysis.

Authors:  I J van der Klei; M Veenhuis
Journal:  Ann N Y Acad Sci       Date:  1996-12-27       Impact factor: 5.691

3.  WT p53, but not tumor-derived mutants, bind to Bcl2 via the DNA binding domain and induce mitochondrial permeabilization.

Authors:  York Tomita; Natasha Marchenko; Susan Erster; Alice Nemajerova; Alexander Dehner; Christian Klein; Hongguang Pan; Horst Kessler; Petr Pancoska; Ute M Moll
Journal:  J Biol Chem       Date:  2006-01-26       Impact factor: 5.157

4.  Selective targeting of an antioxidant to mitochondria.

Authors:  R A Smith; C M Porteous; C V Coulter; M P Murphy
Journal:  Eur J Biochem       Date:  1999-08

5.  Intracellular delivery of a proapoptotic peptide via conjugation to a RAFT synthesized endosomolytic polymer.

Authors:  Craig L Duvall; Anthony J Convertine; Danielle S W Benoit; Allan S Hoffman; Patrick S Stayton
Journal:  Mol Pharm       Date:  2010-04-05       Impact factor: 4.939

6.  Firefly luciferase is targeted to peroxisomes in mammalian cells.

Authors:  G A Keller; S Gould; M Deluca; S Subramani
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

7.  The B subunit of Shiga toxin coupled to full-size antigenic protein elicits humoral and cell-mediated immune responses associated with a Th1-dominant polarization.

Authors:  Nacilla Haicheur; Fabrice Benchetrit; Mohamed Amessou; Claude Leclerc; Thomas Falguières; Catherine Fayolle; Emmanuelle Bismuth; Wolf H Fridman; Ludger Johannes; Eric Tartour
Journal:  Int Immunol       Date:  2003-10       Impact factor: 4.823

Review 8.  Mannose 6-phosphate receptor targeting and its applications in human diseases.

Authors:  M Gary-Bobo; P Nirdé; A Jeanjean; A Morère; M Garcia
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

9.  Intracellular trafficking of metallocarboxypeptidase D in AtT-20 cells: localization to the trans-Golgi network and recycling from the cell surface.

Authors:  O Varlamov; L D Fricker
Journal:  J Cell Sci       Date:  1998-04       Impact factor: 5.285

10.  Intracellular movement of two mannose 6-phosphate receptors: return to the Golgi apparatus.

Authors:  J R Duncan; S Kornfeld
Journal:  J Cell Biol       Date:  1988-03       Impact factor: 10.539

View more
  17 in total

1.  Liposome-like Nanostructures for Drug Delivery.

Authors:  Weiwei Gao; Che-Ming J Hu; Ronnie H Fang; Liangfang Zhang
Journal:  J Mater Chem B       Date:  2013-12-28       Impact factor: 6.331

Review 2.  The emergence of multiple particle tracking in intracellular trafficking of nanomedicines.

Authors:  Anthony J Kim; Justin Hanes
Journal:  Biophys Rev       Date:  2012-02-03

3.  Direct induction of apoptosis using an optimal mitochondrially targeted p53.

Authors:  Mohanad Mossalam; Karina J Matissek; Abood Okal; Jonathan E Constance; Carol S Lim
Journal:  Mol Pharm       Date:  2012-03-28       Impact factor: 4.939

Review 4.  Cellular uptake and intracellular trafficking of oligonucleotides: implications for oligonucleotide pharmacology.

Authors:  R L Juliano; Xin Ming; Kyle Carver; Brian Laing
Journal:  Nucleic Acid Ther       Date:  2014-01-02       Impact factor: 5.486

Review 5.  The cell's nucleolus: an emerging target for chemotherapeutic intervention.

Authors:  Amanda J Pickard; Ulrich Bierbach
Journal:  ChemMedChem       Date:  2013-07-23       Impact factor: 3.466

Review 6.  Transduction of human recombinant proteins into mitochondria as a protein therapeutic approach for mitochondrial disorders.

Authors:  Lefkothea C Papadopoulou; Asterios S Tsiftsoglou
Journal:  Pharm Res       Date:  2011-08-27       Impact factor: 4.200

7.  Controlled access of p53 to the nucleus regulates its proteasomal degradation by MDM2.

Authors:  James R Davis; Mohanad Mossalam; Carol S Lim
Journal:  Mol Pharm       Date:  2013-03-01       Impact factor: 4.939

8.  Utilizing the estrogen receptor ligand-binding domain for controlled protein translocation to the insoluble fraction.

Authors:  James R Davis; Mohanad Mossalam; Carol S Lim
Journal:  Pharm Res       Date:  2012-08-07       Impact factor: 4.200

Review 9.  Targeting malignant mitochondria with therapeutic peptides.

Authors:  Jonathan E Constance; Carol S Lim
Journal:  Ther Deliv       Date:  2012-08

Review 10.  Monitoring of post-translational modification dynamics with genetically encoded fluorescent reporters.

Authors:  Fabian Hertel; Jin Zhang
Journal:  Biopolymers       Date:  2014-02       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.